FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2093727585> ?p ?o ?g. }

• W2093727585 endingPage "1266" @default.
• W2093727585 startingPage "1260" @default.
• W2093727585 abstract "IntroductionBrain metastases frequently cause significant morbidity in patients with non-small cell lung cancer (NSCLC). Sunitinib is a multitargeted inhibitor of tyrosine kinase receptors, including vascular endothelial growth factor receptors and platelet-derived growth factor receptors, which has single-agent antitumor activity in refractory NSCLC. This phase II study evaluated the antitumor activity and safety of sunitinib in patients with pretreated NSCLC and irradiated brain metastases.MethodsPatients received sunitinib 37.5 mg on a continuous daily dosing schedule. The primary end point was progression-free survival. Secondary end points included overall survival, patient-reported outcomes, and safety, including risk of intracranial hemorrhage (ICH) associated with focal neurological deficit.ResultsSixty-four patients received sunitinib (median age 61 years), most (83%) had received prior systemic therapy, 63% had adenocarcinoma, and 19% had squamous cell carcinoma; most (55%) were never-smokers. Median progression-free survival was 9.4 weeks (90% confidence interval [CI]: 7.5–13.1), and median overall survival was 25.1 weeks (95% CI: 13.4–35.5). The most common treatment-emergent (all-causality) nonhematologic toxicities (any grade) were fatigue (38%) and decreased appetite and constipation (both 25%). The most common grade 3/4 nonhematologic toxicities were dyspnea (9%) and fatigue (8%). Lymphopenia (20%) and neutropenia (13%) were the most common grade 3/4 hematologic abnormalities. Serious neurologic adverse events occurred in six patients (9%), and none were treatment-related. No cases of ICH were reported.ConclusionsSunitinib administration on a continuous daily dosing schedule in patients with NSCLC and brain metastases was safe and manageable, with no increased risk of ICH." @default.
• W2093727585 created "2016-06-24" @default.
• W2093727585 creator A5001428569 @default.
• W2093727585 creator A5015049606 @default.
• W2093727585 creator A5032477448 @default.
• W2093727585 creator A5039623202 @default.
• W2093727585 creator A5042341977 @default.
• W2093727585 creator A5045378192 @default.
• W2093727585 creator A5053411791 @default.
• W2093727585 creator A5055246540 @default.
• W2093727585 creator A5074589844 @default.
• W2093727585 creator A5079802303 @default.
• W2093727585 creator A5084965180 @default.
• W2093727585 creator A5085114374 @default.
• W2093727585 date "2011-07-01" @default.
• W2093727585 modified "2023-10-03" @default.
• W2093727585 title "Phase II Study of Sunitinib in Patients with Non-small Cell Lung Cancer and Irradiated Brain Metastases" @default.
• W2093727585 cites W1644726052 @default.
• W2093727585 cites W1961110209 @default.
• W2093727585 cites W1965602476 @default.
• W2093727585 cites W1976689062 @default.
• W2093727585 cites W1979608435 @default.
• W2093727585 cites W1979917491 @default.
• W2093727585 cites W1980011909 @default.
• W2093727585 cites W2004350020 @default.
• W2093727585 cites W2008495442 @default.
• W2093727585 cites W2012945281 @default.
• W2093727585 cites W2014075906 @default.
• W2093727585 cites W2055914441 @default.
• W2093727585 cites W2069510682 @default.
• W2093727585 cites W2073819958 @default.
• W2093727585 cites W2082992113 @default.
• W2093727585 cites W2085678636 @default.
• W2093727585 cites W2088223863 @default.
• W2093727585 cites W2100785570 @default.
• W2093727585 cites W2102996502 @default.
• W2093727585 cites W2106129813 @default.
• W2093727585 cites W2114940128 @default.
• W2093727585 cites W2127045236 @default.
• W2093727585 cites W2129455899 @default.
• W2093727585 cites W2131653589 @default.
• W2093727585 cites W2137510882 @default.
• W2093727585 cites W2139248078 @default.
• W2093727585 cites W2139511378 @default.
• W2093727585 cites W2144660856 @default.
• W2093727585 cites W2145835533 @default.
• W2093727585 cites W2148934793 @default.
• W2093727585 cites W2149032069 @default.
• W2093727585 cites W2157216324 @default.
• W2093727585 cites W2159711942 @default.
• W2093727585 cites W2160120519 @default.
• W2093727585 cites W2165459839 @default.
• W2093727585 cites W2166788033 @default.
• W2093727585 cites W2168161641 @default.
• W2093727585 doi "https://doi.org/10.1097/jto.0b013e318219a973" @default.
• W2093727585 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21610524" @default.
• W2093727585 hasPublicationYear "2011" @default.
• W2093727585 type Work @default.
• W2093727585 sameAs 2093727585 @default.
• W2093727585 citedByCount "42" @default.
• W2093727585 countsByYear W20937275852012 @default.
• W2093727585 countsByYear W20937275852013 @default.
• W2093727585 countsByYear W20937275852014 @default.
• W2093727585 countsByYear W20937275852015 @default.
• W2093727585 countsByYear W20937275852016 @default.
• W2093727585 countsByYear W20937275852018 @default.
• W2093727585 countsByYear W20937275852019 @default.
• W2093727585 countsByYear W20937275852020 @default.
• W2093727585 countsByYear W20937275852021 @default.
• W2093727585 countsByYear W20937275852022 @default.
• W2093727585 crossrefType "journal-article" @default.
• W2093727585 hasAuthorship W2093727585A5001428569 @default.
• W2093727585 hasAuthorship W2093727585A5015049606 @default.
• W2093727585 hasAuthorship W2093727585A5032477448 @default.
• W2093727585 hasAuthorship W2093727585A5039623202 @default.
• W2093727585 hasAuthorship W2093727585A5042341977 @default.
• W2093727585 hasAuthorship W2093727585A5045378192 @default.
• W2093727585 hasAuthorship W2093727585A5053411791 @default.
• W2093727585 hasAuthorship W2093727585A5055246540 @default.
• W2093727585 hasAuthorship W2093727585A5074589844 @default.
• W2093727585 hasAuthorship W2093727585A5079802303 @default.
• W2093727585 hasAuthorship W2093727585A5084965180 @default.
• W2093727585 hasAuthorship W2093727585A5085114374 @default.
• W2093727585 hasBestOaLocation W20937275851 @default.
• W2093727585 hasConcept C121608353 @default.
• W2093727585 hasConcept C126322002 @default.
• W2093727585 hasConcept C141071460 @default.
• W2093727585 hasConcept C143998085 @default.
• W2093727585 hasConcept C197934379 @default.
• W2093727585 hasConcept C2776256026 @default.
• W2093727585 hasConcept C2776694085 @default.
• W2093727585 hasConcept C2777063308 @default.
• W2093727585 hasConcept C2779490328 @default.
• W2093727585 hasConcept C71924100 @default.
• W2093727585 hasConcept C90924648 @default.
• W2093727585 hasConceptScore W2093727585C121608353 @default.
• W2093727585 hasConceptScore W2093727585C126322002 @default.
• W2093727585 hasConceptScore W2093727585C141071460 @default.

• next